Lead party: Alitheia Capital Limited (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Cipher Genetics, Inc. (private company) · Sector: Healthcare, Digital Health Platforms, Biotechnology · Countries of operation: South Africa
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Round: Series A · Deal amount: US$2.5m
Lead investor/buyer: Alitheia Capital Limited · Investors/buyers: Alitheia Capital Limited
Legal advisers: not identified in the source record.
Source: announced 20 December 2019. Original announcement: disruptafrica.com.


